NONOCCLUSIVE mesenteric infarction is a clinical state of increasing incidence and surgical significance.1 In the classic case an elderly patient with atherosclerotic heart disease sustains an acute stress such as an infection or a surgical procedure. The increased circulatory demand cannot be met, and so splanchnic vasoconstriction occurs and causes intestinal mucosal damage. This produces a series of events which ends in a low-flow state with hypovolemia, sepsis, perhaps edotoxemia, and myocardial failure. To date, therapy has seldom prevented a fatal outcome and some have suggested2 that "only serendipity can provide us with effective treatment." Therefore, an experimental model on which therapy could be evaluated would have significance. This report presents data from an experimental model which simulated the clinical disease nonocclusive mesenteric ischemia.
All experimental studies were done on mongrel dogs of both sexes weighing between 8 and 25 kg (18 and 56 lb) and were
Williams LF, Anastasia LF, Hasiotis CA, Bosniak MA, Byrne JJ. Experimental Nonocclusive Mesenteric Ischemia: Physiologic and Anatomic Observations. Arch Surg. 1968;96(6):987–994. doi:10.1001/archsurg.1968.01330240133032
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: